RBC Capital Assumes Flexion Therapeutics (FLXN) at Outperform

April 6, 2021 4:27 PM EDT
Get Alerts FLXN Hot Sheet
Price: $9.38 -0.21%

Rating Summary:
    17 Buy, 1 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 18 | Down: 8 | New: 31
Trade Now! 
Join SI Premium – FREE

RBC Capital analyst Daniel Busb assumes coverage on Flexion Therapeutics (NASDAQ: FLXN) with a Outperform rating and a price target of $18.00.

For an analyst ratings summary and ratings history on Flexion Therapeutics click here. For more ratings news on Flexion Therapeutics click here.

Shares of Flexion Therapeutics closed at $8.82 yesterday.

You May Also Be Interested In

Related Categories

New Coverage